Glucosio Con Potassio Cloruro I Bioindustria L.I.M.

Glucosio Con Potassio Cloruro I Bioindustria L.I.M. is an injectable solution that combines potassium chloride and glucose monohydrate in a sterile aqueous formulation. It is supplied as a prescription‑only product for intravenous administration in the European market, intended to replace fluid and electrolyte losses and to correct low potassium levels.

Glucosio Con Potassio Cloruro I is indicated for clinical situations where rapid restoration of potassium and fluid balance is required. It is commonly employed in the following contexts: - Treatment of hypokalemia or potassium depletion. - Fluid replacement therapy after surgery or trauma. - Management of electrolyte disturbances during acute illness. - Support during postoperative recovery when potassium losses are anticipated. - Adjunct to intravenous nutrition regimens that lack adequate potassium. - Emergency care for patients with severe electrolyte imbalance.

Side effects may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after infusion.

Common: - Mild injection site irritation or pain. - Transient nausea or vomiting. - Temporary hyperglycemia. - Slight increase in serum potassium that resolves spontaneously.

Serious: - Severe hyperkalemia leading to cardiac arrhythmia. - Anaphylactic or severe allergic reaction. - Significant electrolyte disturbances (e.g., hypernatremia). - Phlebitis or thrombophlebitis at the infusion site.

Before using Glucosio Con Potassio Cloruro I, clinicians should consider several safety factors. Appropriate assessment helps minimize risk: - Verify baseline serum potassium, glucose, and renal function. - Adjust dose in patients with renal insufficiency or heart failure. - Use caution in individuals with diabetes or impaired glucose tolerance. - Avoid rapid infusion rates that may cause cardiac irritation. - Monitor cardiac rhythm in patients at risk for arrhythmias. - Discontinue if signs of severe hyperkalemia develop. - Ensure aseptic technique to prevent infection.

Glucosio Con Potassio Cloruro I can interact with other medications that affect potassium balance or glucose metabolism.

Avoid: - Concurrent use of other potassium supplements or potassium‑sparing diuretics without monitoring. - Co‑administration with insulin or insulin secretagogues without glucose monitoring. - Simultaneous infusion of high‑dose calcium gluconate, which may precipitate potassium.

Use with caution: - ACE inhibitors, ARBs, or NSAIDs that may alter renal potassium handling. - Beta‑blockers that can mask hypoglycemia symptoms. - Digoxin, as altered potassium levels can affect its toxicity. - Loop diuretics, which may exacerbate potassium loss. - Corticosteroids, which can influence glucose levels.